December 9, 2011 -- Beijing SL Pharmaceutical will invest 90 million RMB ($14 million) to buy new shares of Forwell Biopharm Co., giving Beijing SL an 18% stake in Forwell. Forwell’s major product is a human Adsorbed Rabies vaccine, which is administered before or after exposure to rabies. The transaction is the second investment Beijing SL has made in a vaccine company this year. More details....
Stock Symbol: (SHE: 002038)
